Further backing for HPV (human papillomavirus) screening:
This article was originally published in Clinica
A team of Scandinavian cancer researchers has provided further evidence that screening for human papillomavirus (HPV) in conjunction with cervical Pap smears would improve detection of cervical cancer. There is a growing body of evidence suggesting that persistent HPV infection causes cancer, and the latest study, in the November 25 edition of the New England Journal of Medicine, researchers led Dr Keng-Ling Wallin of the Karolinska Institute in Stockholm found that a single positive finding of HPV DNA in a Pap smear confers an increased risk of cancer that is positive for the same virus.
You may also be interested in...
The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals starts a Phase I trial of a DHODH inhibitor.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.